Among 52 HCC samples we examined, eleven (21%) of them showed genomic amplification of SGCE, PEG10 and DYNC1I1 respectively, and 23 (44%) of them exhibited genomic amplification of SLC25A13. This evidence concerns the gene DYNC1I1 and hepatocellular carcinoma.